CD69 Protein

CD69 Protein

Introduction

The CD69 protein (CD69 Molecule) is a C-type lectin receptor family member involved in Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@immune]
<table> [@neurodegenerative]
<tr><th colspan="2" style="background-color: #e65100; color: white;">CD69 (CD69 Molecule)</th></tr> [@therapeutic]
<tr><td><strong>Official Symbol</strong></td><td>CD69</td></tr> [@expression]
<tr><td><strong>Gene</strong></td><td>CD69</td></tr> [@gpcr]
<tr><td><strong>Chromosomal Location</strong></td><td>12p13.31</td></tr> [@neuroinflammation]
<tr><td><strong>UniProt ID</strong></td><td>Q07108</td></tr> [@clinical]
<tr><td><strong>Molecular Weight</strong></td><td>22-28 kDa (glycosylated)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane, early endosomes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>C-type lectin receptor family</td></tr>
</table>
</div>

Overview

Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.

Normal Function

Signaling Pathways

CD69 participates in key signaling cascades:

• G-protein coupled receptor signaling (for GPCR family members)
• Calcium signaling
• cAMP/PKA pathway modulation
• MAPK/ERK pathway activation

CD69 Protein

Introduction

The CD69 protein (CD69 Molecule) is a C-type lectin receptor family member involved in Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@immune]
<table> [@neurodegenerative]
<tr><th colspan="2" style="background-color: #e65100; color: white;">CD69 (CD69 Molecule)</th></tr> [@therapeutic]
<tr><td><strong>Official Symbol</strong></td><td>CD69</td></tr> [@expression]
<tr><td><strong>Gene</strong></td><td>CD69</td></tr> [@gpcr]
<tr><td><strong>Chromosomal Location</strong></td><td>12p13.31</td></tr> [@neuroinflammation]
<tr><td><strong>UniProt ID</strong></td><td>Q07108</td></tr> [@clinical]
<tr><td><strong>Molecular Weight</strong></td><td>22-28 kDa (glycosylated)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane, early endosomes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>C-type lectin receptor family</td></tr>
</table>
</div>

Overview

Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.

Normal Function

Signaling Pathways

CD69 participates in key signaling cascades:

• G-protein coupled receptor signaling (for GPCR family members)
• Calcium signaling
• cAMP/PKA pathway modulation
• MAPK/ERK pathway activation

Physiological Roles

Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. In the central nervous system, this protein:

• Modulates neurotransmitter release
• Regulates neuronal excitability
• Influences neuroimmune interactions
• Affects circadian rhythm mechanisms

Protein Structure

Domains

• Extracellular domain: Ligand binding
• Transmembrane domains: 7TM architecture (for GPCR family)
• Intracellular domain: G-protein coupling and signaling

Post-translational Modifications

• N-glycosylation: Affects ligand binding and trafficking
• Phosphorylation: Modulates receptor activity
• Palmitoylation: Affects membrane localization

Disease Associations

Alzheimer's Disease

CD69 is implicated in Alzheimer's disease through:

• [Neuroinflammation](/mechanisms/neuroinflammation-neurodegeneration) modulation
• [Amyloid](/mechanisms/amyloid-cascade-pathway) interactions
• [Tau](/mechanisms/tau-pathology) pathology involvement
• Synaptic function regulation

Parkinson's Disease

In Parkinson's disease:

• Dopaminergic signaling modulation
• [Neuroinflammation](/mechanisms/neuroinflammation-neurodegeneration) response
• Mitochondrial function effects

Neuroimmune Interactions

CD69 plays a role in:

• Microglial activation states
• Peripheral immune-brain communication
• Inflammatory cytokine regulation

Therapeutic Implications

Drug Targets

CD69 is being investigated as a therapeutic target:

• Agonists: Enhancing neuroprotective signaling
• Antagonists: Modulating pathological immune activation
• Allosteric modulators: Fine-tuning receptor activity

Clinical Applications

• Biomarker potential for neuroinflammation
• Patient stratification markers
• Therapeutic monitoring endpoints

Interactions

Molecular Partners

CD69 interacts with:

• [Neuroinflammation pathway](/mechanisms/neuroinflammation-neurodegeneration)
• [Synaptic dysfunction pathway](/mechanisms/synaptic-dysfunction-neurodegeneration)
• [Mitochondrial dysfunction pathway](/mechanisms/mitochondrial-dysfunction-parkinsons)
• [Circadian clock pathway](/mechanisms/circadian-clock-pathway)

Signaling Cascades

• G-protein mediated signaling
• Calcium homeostasis
• cAMP signaling
• MAPK/ERK pathway

See Also

• [CD69 Gene](/genes/cd69)
• [Proteins Index](/proteins)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-neurodegeneration)
• [GPCR Signaling in Neurodegeneration](/mechanisms)

External Links

• [UniProt: Q07108](https://www.uniprot.org/uniprot/Q07108)
• [NCBI Gene: CD69](https://www.ncbi.nlm.nih.gov/gene/)
• [Protein Data Bank: CD69](https://www.rcsb.org/)
• [GeneCards: CD69](https://www.genecards.org/)

Background

The study of Cd69 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References